Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 4/20 | 0.34 |
| ▸ | LIMK2 | P53671 | 2/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.30 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.30 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.30 |
| ▸ | TNKS | O95271 | 1/20 | 0.30 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26855358 | 0.97 | LIMK1 (0.33) | LIMK1LIMK2TNKSTNKS2ALOX5 | |
| SCHEMBL26855445 | 0.92 | LIMK1 (0.33) | LIMK1LIMK2 | |
| SCHEMBL26855344 | 0.90 | LIMK1 (0.34) | LIMK1LIMK2 | |
| SCHEMBL26855075 | 0.88 | LIMK1 (0.35) | LIMK1LIMK2TNKSTNKS2ALOX5 | |
| SCHEMBL26855448 | 0.88 | LIMK1 (0.32) | LIMK1 | |
| SCHEMBL26855346 | 0.87 | LIMK1 (0.32) | LIMK1LIMK2 | |
| SCHEMBL26855082 | 0.87 | LIMK1 (0.34) | LIMK1LIMK2 | |
| SCHEMBL23740558 | 0.86 | PRKDC (0.33) | — | |
| SCHEMBL26855050 | 0.85 | LIMK1 (0.32) | LIMK1LIMK2TNKSTNKS2ALOX5 | |
| SCHEMBL23740357 | 0.85 | LIMK1 (0.31) | LIMK1PIM1PIM3PIM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230380283-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO.,LTD. (KR) | 2023-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230380283-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE | CYP1B1, CYP4F11, NOTUM | LIMK1 356/4885LIMK2 1051/4885PIM1 794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.